|
Volumn 2, Issue 2, 2011, Pages 62-65
|
U.S. Regulatory Considerations for Heart Valves Implanted by Minimally Invasive Surgery
|
Author keywords
Percutaneous heart valves; Regulatory; Standards
|
Indexed keywords
CLINICAL TRIAL;
DYNAMIC ENVIRONMENTS;
FOOD AND DRUG ADMINISTRATION;
GUIDANCE DOCUMENT;
HEART VALVES;
IMPLANTATION SITES;
IN-VITRO;
IN-VIVO;
ISO STANDARDS;
MEDICAL DEVICES;
MINIMALLY INVASIVE SURGERY;
NEW MATERIAL;
OPEN-HEART SURGERY;
PROSTHETIC HEART VALVE;
RANDOMIZED CONTROLLED TRIAL;
REGULATORY;
REGULATORY CONSIDERATIONS;
TESTING REQUIREMENTS;
BIOMEDICAL ENGINEERING;
EXPERIMENTS;
MATERIALS TESTING;
SAFETY VALVES;
SURGERY;
HEART;
ARTICLE;
CLINICAL EVALUATION;
CLINICAL TRIAL (TOPIC);
DEVICE SAFETY;
GOVERNMENT REGULATION;
HEART VALVE PROSTHESIS;
HEART VALVE REPLACEMENT;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
MINIMALLY INVASIVE SURGERY;
NONHUMAN;
PRACTICE GUIDELINE;
UNITED STATES;
|
EID: 79955843141
PISSN: 1869408X
EISSN: 18694098
Source Type: Journal
DOI: 10.1007/s13239-010-0031-5 Document Type: Article |
Times cited : (3)
|
References (10)
|